Adaptin Bio, Inc.
APTN
OTC PK
Recommendation
Dividend Power Score
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.64M | 3.12M | 2.53M | 1.43M | 745.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.42M | 4.56M | 3.87M | 3.12M | 2.57M |
| Operating Income | -5.42M | -4.56M | -3.87M | -3.12M | -2.57M |
| Income Before Tax | -5.17M | -4.66M | -4.09M | -3.39M | -3.12M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.17 | -4.66 | -4.09 | -3.39 | -3.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.17M | -4.66M | -4.09M | -3.39M | -3.12M |
| EBIT | -5.42M | -4.56M | -3.87M | -3.12M | -2.57M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.64 | -0.75 | -0.89 | -0.96 | -0.96 |
| Normalized Basic EPS | -0.44 | -0.46 | -0.55 | -0.60 | -0.56 |
| EPS Diluted | -0.65 | -0.75 | -0.89 | -0.96 | -0.96 |
| Normalized Diluted EPS | -0.44 | -0.46 | -0.55 | -0.60 | -0.56 |
| Average Basic Shares Outstanding | 31.22M | 25.99M | 20.78M | 15.58M | 13.00M |
| Average Diluted Shares Outstanding | 31.22M | 25.99M | 20.78M | 15.58M | 13.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |